Effective Control: How Surgical Bleeding Control Is Evolving with Recombinant Technology
The Topical Recombinant Human Thrombin Market is experiencing transformative growth as surgical bleeding control continues to evolve with advanced recombinant technology. According to market reports, the global Topical Recombinant Human Thrombin Market was valued at USD 656.6 million in 2024 and is projected to reach USD 1,200 million by 2035, exhibiting a CAGR of 5.6% during the...
0 Yorumlar 0 hisse senetleri 148 Views 0 önizleme